ArticleFrontiers in bioengineering and biotechnology2019
Deep Learning With Sampling in Colon Cancer Histology.
Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 73 citations in OpenAlex.
- Personalizing adjuvant therapy for patients with colorectal cancer.Nature reviews. Clinical oncology · 2024Review
- Advancements and Challenges in the Image-Based Diagnosis of Lung and Colon Cancer: A Comprehensive Review.Cancer informatics · 2024Review
- Article
- Exploration and Enhancement of Classifiers in the Detection of Lung Cancer from Histopathological Images.Diagnostics (Basel, Switzerland) · 2023Article
- Recent Advancements in Deep Learning Using Whole Slide Imaging for Cancer Prognosis.Bioengineering (Basel, Switzerland) · 2023Review
- Toward next-generation endoscopes integrating biomimetic video systems, nonlinear optical microscopy, and deep learning.Biophysics reviews · 2023Review
- Histopathology image classification: highlighting the gap between manual analysis and AI automation.Frontiers in oncology · 2023Article
- The role of deep learning in diagnosing colorectal cancer.Przeglad gastroenterologiczny · 2023Review
- Cancer-associated fibroblasts: The chief architect in the tumor microenvironment.Frontiers in cell and developmental biology · 2023Review
- Colon Cancer Diagnosis Based on Machine Learning and Deep Learning: Modalities and Analysis Techniques.Sensors (Basel, Switzerland) · 2022Review
- Deep Neural Network Models for Colon Cancer Screening.Cancers · 2022Review
- Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review.Diagnostics (Basel, Switzerland) · 2022Review
- Molecular Pathology of Lung Cancer.Cold Spring Harbor perspectives in medicine · 2022Review
- The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers.Computational and structural biotechnology journal · 2022Review
- Automatic Detection and Segmentation of Colorectal Cancer with Deep Residual Convolutional Neural Network.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.Scientific reports · 2021Article
- Colon Tissues Classification and Localization in Whole Slide Images Using Deep Learning.Diagnostics (Basel, Switzerland) · 2021Article
- Requirements for implementation of artificial intelligence in the practice of gastrointestinal pathology.World journal of gastroenterology · 2021Review
- A generalized deep learning framework for whole-slide image segmentation and analysis.Scientific reports · 2021Article
- State of machine and deep learning in histopathological applications in digestive diseases.World journal of gastroenterology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study applied a deep-learning cell identification algorithm to diagnostic images from the colon cancer repository at The Cancer Genome Atlas (TCGA). Within-image sampling improved performance without loss of accuracy. The features thus derived were associated with various clinical variables including metastasis, residual tumor, venous invasion, and lymphatic invasion. The deep-learning algorithm was trained using images from a locally available data set, then applied to the TCGA images by tiling them, and identifying cells in each patch defined by the tiling. In this application the average number of patches containing tissue in an image was ~900. Processing a random sample of patches greatly reduced computation costs. The cell identification algorithm was applied directly to each sampled patch, resulting in a list of cells. Each cell was labeled with its location and classification ("epithelial," "inflammatory," "fibroblast," or "other"). The number of cells of a given type in the patch was calculated, resulting in a patch profile containing four features. A morphological profile that applied to the entire image was obtained by averaging profiles over all patches. Two sampling policies were examined. The first policy was random sampling which samples patches with uniform weighting. The second policy was systematic random sampling which takes spatial dependencies into account. Compared with the processing of complete whole slide images there was a seven-fold improvement in performance when systematic random spatial sampling was used to select 100 tiles from the whole-slide image for processing, with very little loss of accuracy (~4% on average). We found links between the predicted features and clinical variables in the TCGA colon cancer data set. Several significant associations were found: increased fibroblast numbers were associated with the presence of metastasis, venous invasion, lymphatic invasion and residual tumor while decreased numbers of inflammatory cells were associated with mucinous carcinomas. Regarding the four different types of cell, deep learning has generated morphological features that are indicators of cell density. The features are related to cellularity, the numbers, degree, or quality of cells present in a tumor. Cellularity has been reported to be related to patient survival and other diagnostic and prognostic indicators, indicating that the features calculated here may be of general usefulness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.